โ† All deals

LENSAR, INC.

Public Equity (NASDAQ)Medical DeviceB2BLaser Technology
๐Ÿ“ Orlando, FL, United Statesโ€ข Founded 2004โ€ข 100-200 employees
StreetZero Signal 53
Be the first to signal interest

About LENSAR, INC.

LENSAR, Inc. is a commercial-stage medical device company founded in 2004 and headquartered in Orlando, Florida. It designs, develops, and markets laser systems for cataract treatment and management of corneal astigmatism, with flagship products including the LENSAR Laser System and ALLY Robotic Cataract Laser System. The company operates on a B2B model, serves ophthalmologists and surgical centers globally, and is publicly traded on NASDAQ under the ticker LNSR.

LATEST FUNDINGRule 144
$54K
Announced 2026-11-18
TOTAL RAISED$178M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for LENSAR, INC..

Free plan includes 3 full deal profiles every month.

EMPLOYEES100-200
FOUNDED2004
HQOrlando, FL, United States
Industry
Public Equity (NASDAQ)
Tags
Medical DeviceB2BLaser Technology

Key highlights

  • Raised approximately $178 million over 14-15 rounds with historical rounds including $16M Private Equity in 2015.
  • Backed by investors including Aisling Capital and Florida Growth Fund.
  • Publicly traded on NASDAQ under ticker LNSR.
  • Acquired by Alcon in March 2025.
  • Develops robotic femtosecond laser systems for cataract surgery with 100-200 employees.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account